No Data
No Data
CSC: Rich pipeline of IL-17A and other target drugs, related drugs are expected to gradually achieve domestic production.
There is a rich pipeline of targeted drugs for IL-17A, IL-4R, JAK, IL-23, and other targets, some of which have already been approved for domestic pipelines or applied for approval. Relevant drugs are expected to gradually achieve domestic production in the treatment of autoimmune diseases in China.
Shanghai supports the use of AI technology in drug research and development, and continues to increase its support for the development of innovative drugs.
On July 30, the Shanghai Municipal People's Government Office issued several opinions on supporting the innovative development of the entire biomedical industry chain.
Hong Kong stock concept tracking | Diabetes prevention and control action plan released, significant progress has been made in the innovative drug research and development of these enterprises (with concept stocks).
According to Frost & Sullivan data, the scale of China's diabetes medication market is expected to reach 167.5 billion yuan by 2030.
HUTCHMED (China) Limited's (LON:HCM) Last Week's 6.4% Decline Must Have Disappointed Private Equity Firms Who Have a Significant Stake
Hong Kong stocks soar | Hutchmed (China) (00013) rises over 5% again. The company has recently introduced progress in innovative drugs. Institutions say that research and development progress is rapid.
Hutchmed (China) (00013) rose more than 5%, as of publication, up 5.41%, reported at HKD 31.2, with a turnover of HKD 44.2823 million.
China Securities Co.,Ltd: Accelerating development of the self-immunity market to promote the improvement and efficiency of the domestic innovative drug industry.
The patient population with autoimmune diseases and type II inflammation is growing rapidly, the market size is second only to cancer drugs, but still in a period of accelerated development. Existing drugs still have huge room for improvement in efficacy and safety.
No Data
DailyHunt : Do you think is ready?
Momentum Trader OP DailyHunt : Already Bo from pivot. Don’t chase high!